IMI has been a leader in medical device innovation for over 50 years, specializing in the design and manufacturing of both sterile and non-sterile single-use medical devices. Renowned for our commitment to excellence and reliability, IMI has earned a strong reputation within the healthcare industry. Our flagship product, the Prep-Lock™ Tamper-Evident Caps, has established IMI as the global leader in tamper-evident technology. These advanced solutions play a critical role in safeguarding the integrity of compounded medications, providing an essential layer of protection against unauthorized access. Our tamper-evident products are key components of comprehensive drug security programs, ensuring both patient safety and regulatory compliance. Additionally, IMI offers a broad range of sterile single-use devices, specifically designed for pharmacy compounding, all manufactured in the USA at our state-of-the-art, FDA registered, ISO certified facility in Pompano Beach, FL.
The EAHP Board, elected for three-year terms, oversees the association’s activities. Comprising directors responsible for core functions, it meets regularly to implement strategic goals. Supported by EAHP staff, the Board controls finances, coordinates congress organization, and ensures compliance with statutes and codes of conduct.
